Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MAP3K13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ODF3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C11orf65 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALDOB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP6V1C1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PUS10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPHLN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927051 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STXBP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYTL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM171B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NLN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARD6B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FITM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on